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Background: It is estimated that venoms of marine cone snails (genus Conus) contain more than 100,000 different
small peptides with a wide range of pharmacological and biological actions. Some of these peptides were
developed into potential therapeutic agents and as molecular tools to understand biological functions of nervous
and cardiovascular systems. In this study we examined the cytotoxic and anticancer properties of the marine
vermivorous cone snail Conus vexillum (collected from Hurgada and Sharm El-Shaikh, Red Sea, Egypt) and suggest
the possible mechanisms involved. The in vitro cytotoxic effects of Conus venom were assessed against Ehrlich’s
ascites carcinoma (EAC) cells.
Results: Conus venom treatment resulted in concentration-dependent cytotoxicity as indicated by a lactate
dehydrogenase leakage assay. Apoptotic effects were measured in vivo by measuring levels of reactive oxygen
species and oxidative defense agents in albino mice injected with EAC cells. Conus venom (1.25 mg/kg) induced a
significant increase (p < 0.05) in several oxidative stress biomarkers (lipid peroxidation, protein carbonyl content and
reactive nitrogen intermediates) of EAC cells after 3, 6, 9 and 12 hours of venom injection. Conus venom
significantly reduced (p < 0.05) the activities of oxidative defense enzymes (catalase and superoxide dismutase) as
well as the total antioxidant capacity of EAC cells, as evidenced by lowered levels of reduced glutathione.
Conclusions: These results demonstrate the cytotoxic potential of C. vexillum venom by inducing oxidative stress
mediated mechanisms in tumor cells and suggest that the venom contains novel molecules with potential
anticancer activity.
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It is acknowledged that natural products are one of the
major sources for drug discovery and used to treat sev-
eral life-threading diseases including cancer [1]. Venoms
of animal species (such as snakes, scorpions, spiders and
cone snails) are a combination of unique bioactive mole-
cules that display a plethora of molecular targets and
functions. Some of these molecules are currently being
developed as candidate or to provide a critical template
for the design of others [2].* Correspondence: mohamed_hassanain@science.suez.edu.eg
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distribution, and reproduction in any mediumCancer is defined as a disturbance in mechanisms
involved in the control of cell growth and division [3,4].
It is well known that resistance to apoptotic signals is
one of the characteristic features of cancer cells [5].
Chemotherapy is the usage of conventional antitumor
drugs to treat several types of cancerous cells. While
chemotherapy can be quite effective in treating advanced
or metastatic diseases, it often accompanied with many
harmful side-effects through inducing severe damage
to normal cells and tissues [6-8]. Moreover through
particular cellular and molecular changes, cancer cells
eventually become not susceptible to chemotherapeutic
agents. These changes include up-regulation the en-
zymes of drug detoxification and drug transporters andCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tolerance may be due to increase the ability of cancer
cells to evade apoptosis through suppression apoptotic
pathways and improve the machinery of DNA repair
[9-11]. Thus, development of alternative anticancer
drugs with minimal side-effects is urgently required.
The scientific literature on the antitumor activities of
snake venoms extends back many decades [12,13]. More
recently, peptides with specific antitumor activity have
been isolated, such as cystatin [14]. However the high
toxicity of snake venoms often halts their therapeutic
properties and in most cases, the cytotoxic doses for
malignant and normal cells are the same. In addition to
snake venom, anti-cancer efficacy of bee venom has
been reported using both in vitro and in vivo approaches
[15,16]. Bee venom has been reported to be cytotoxic
and induce apoptosis in various tumour cell lines
[17,18]. The promotion of apoptosis through several
cancer cell death mechanisms is essential for bee
venom-induced anticancer effects (and the bee venom
peptide, melittin) [19]. Scorpion venom also possess
the property of inhibiting growth of various types of
cancers [20]. Several cytotoxic antitumor peptides have
been characterized from scorpion venom, which exert
their action by distinct mechanisms: as an ion channel
blocker, as a matrix metalloproteinase (MMP-2) inhibi-
tor and as an apoptosis inducer, activating intracellular
pathways [21-23].
The venoms of cone snails, a family of widely distrib-
uted marine mollusks, contain a large number of small
peptides (conotoxins and conopeptides) which have
evolved separately in approximately 700 species of spe-
cific fish, mollusk and worm-hunting animals [24]. It is
estimated that more than 50,000 conopeptides exist, but
less than 0.1% have been functionally characterized.
Those that have been examined are specific for an amaz-
ingly diverse set of important pharmacological targets,
including voltage gated ion channels (Na, K, Ca), neuro-
transmitter receptors (acetylcholine, glutamate) and
transporters (noradrenaline) [2]. Their small size, relative
ease of synthesis and structural stability also make them
important templates for the design of novel drugs and
indeed several are presently in clinical trials [25].
We have recently demonstrated that crude venom of the
vermivorous snail C. vexillum caused an array of cytotoxic
effects in mammalian systems which were attributed to
the venom’s ability to induce oxidative stress [26]. Venoms
collected from different locations in the Red Sea (Hurgada
and Sharm El-Shaikh) also showed clear differences in
venom potency. The present study was designed to extend
our earlier work, by examining the cytotoxic activity and
mechanism of action of C. vexillum venom on EAC cells,
both in vitro and in vivo. To the best of our knowledge,
this is the first study of its kind on this Conus species.Methods
Venom preparation
Specimens of C. vexillum were collected from two differ-
ent sites (Hurgada and Sharm El-Shaikh) in the Red Sea,
Egypt [26]. Venom glands were dissected as described
previously by Cruz et al. [27] and crude venom from
each location was extracted and lyophilized [26]. Pooled
venoms were stored at −80°C until further use.
Experimental animals and ascites tumor
All animal procedures and experimental protocols were ap-
proved by the Research Ethics Committee of Suez Canal
University and were carried out in accordance with the
Guide for the Care and Use of Laboratory Animals (http://
www.nap.edu/catalog/12910.html). Adult male Swiss albino
mice weighing 20–25 g were purchased from the breeding
unit of Theodor Bilharz Research Institute (Giza, Egypt).
The animals were maintained under controlled conditions
of temperature, humidity and on a 12 hour-light/dark cycle,
with free access to standard pellet diet and water. The first
inoculum of EAC cell line was purchased from the Depart-
ment of Tumor Biology, National Cancer Institute, Cairo
University. The cell line was inoculated by serial intraperi-
toneal (IP) passages of 106 cells per mouse. Cells were
grown in the peritoneal cavity of mice and transferred every
ten days to new animals. Mice were monitored daily for
signs of tumor progression, including the amount of
abdominal distension and signs of illness and distress.
The volume of ascites fluid was determined by needle
(18–22 gauge) aspiration. Withdrawal of ascites fluid
was performed under aseptic conditions.
Isolation of EAC cells
Based on the method described by Mookerjee et. al. [28]
peritoneal fluid containing the tumor cells was with-
drawn, collected in sterile petri plates and incubated at
37°C for two hours. The cells of macrophage lineage
adhered to the bottom of the petri dishes. Since EAC
cells do not adhere to synthetic surfaces in vitro, the
non-adherent cell population was gently aspirated and
washed repeatedly with phosphate buffered saline [29].
More than 93% of the non-adherent cells were mor-
phologically characterized as EAC cells by Wright
staining [30] and viability was assessed by Trypan Blue
dye exclusion [31].
Lactate dehydrogenase (LDH) assay
EAC cells (1 × 106 cells/mL) were incubated in a 96-well
plate with varying concentrations (10, 20 and 30 μg/mL)
of C. vexillum venom for one hour at 37°C. LDH re-
leased into the medium was determined spectrophoto-
metrically (340 nm) by measuring the rate of decrease of
NAPDH, using commercial kit (Spinreact, Sant Esteve
de Bas, Spain). Data was expressed as units/liter (U/L).
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The antitumor activity of C. vexillum venom from each
geographical location was evaluated. Fifty-four mice were
inoculated with the EAC cells as previously mentioned.
After successful establishment of the tumor (ten days after
tumor inoculation), mice were randomly assorted into
three groups. A Hurgada-treated group (24 animals) and a
Sharm El-Shaikh-treated group (24 animals) were both
injected IP with a sublethal dose of C. vexillum venom
(1.25 mg/kg) [26]. A third control group (six animals) was
injected with 100 μL of sterile saline.
Ascites fluid containing EAC cells was drawn from the
peritoneal cavity of treated and control groups after 3, 6,
9 and 12 hours of venom administration. The following
biochemical parameters were measured in the EAC cells
of treated and control groups: the level of lipid peroxi-
dation (LPx) and protein carbonyl contents (PCC),
glutathione (reduced form) content (GSH), the activ-
ities of Cu/Zn-superoxide dismutase (Cu/Zn-SOD),
catalase (CAT) and total antioxidant capacity (TAC).
The level of nitric oxide (NO) was measured in the
supernatant of ascites fluid.Malondialehyde (MDA) assay
The extent of lipid peroxidation in EAC cells was deter-
mined by measuring the production of malondialdehyde,
an indicator of oxidative damage and oxidative stress
[31]. Malondialdehyde was determined by incubating
samples with thiobarbituric acid and measuring reaction
products at 532 nm [32]. 1,1,3,3-tetramethoxypropane
[malonaldehyde bis(dimethyl acetal), Sigma-Aldrich,
USA] was used as an external standard and the results
were expressed as μmoles of MDA/mg.Protein carbonyl content (PCC)
PCC was quantified using dinitrophenylhydrazide
(DNPH) [33]. Protein was precipitated with an equal
volume of 1% trichloroacetic acid (TCA) and the pellet
was resuspended in 1 mL of 2,4- dinitrophenylhydrazide
(Sigma-Aldrich, USA), 10 mM, dissolved in 2 N HCl. Based
on the method described by Fulle et al. [34], separate
blanks were prepared by adding 1 mL of 2 N HCl without
DNPH. Samples were left at room temperature for one
hour in the dark and vortexed every 15 minutes. An equal
volume of 20% TCA was added and after centrifugation
(12,000 × g, 15 minutes, 4°C), pellets were washed (three
times) with 1 mL of ethanol: ethyl acetate (1:1) to remove
free DNPH and lipid contaminants. The final pellet was
dissolved in 6 M guanidine (1 mL, 1 hour, 37°C shaking
water bath). The solution was centrifuged (12,000 × g, 15
minutes) and the carbonyl content (nmol/mg), measured as
protein phenylhydrazone derivatives, was determined at
370 nm using an absorption coefficient of 22,000 M−1 Cm1.Estimation of nitric oxide (NO)
Nitric oxide was measured in the supernatant of ascites
fluid by a spectrophotometric method based on the Griess
reaction [35]. One hundred microliters of supernatant was
mixed with an equal volume of Griess reagent (one part
0.1% naphthylethylendiamine dihydrochloride in distilled
water plus one part 1% sulfanilamide in 5% concentrated
H3PO4), at room temperature for ten minutes. The ab-
sorbance was measured at 540 nm. Sodium nitrite was
used as a standard.
Reduced glutathione (GSH)
The content of glutathione in EAC cells of control and
treated groups was estimated according to Beutler et al.
[36]. Aliquots of 0.2 mL of ascites fluid were added to
1.8 mL distilled water and 3 mL of precipitating solution
(1.67 gm glacial metaphosphoric acid, 0.2 gm EDTA and
30 gm NaCl in 100 mL distilled water) and the mixture
was centrifuged (2200 × g, 15 minutes, 4°C). To 1 mL
of supernatant it was added sequentially, sodium
dihydrogen phosphate (4 mL, 0.3 M) and DTNB re-
agent [0.5 mL, 40 mg 5,5` dithiobis-2-nitrobenzoic
acid (Sigma-Aldrich, USA) dissolved in 100 mL 1%
sodium citrate] and the absorbance was measured at
412 nm. Reduced glutathione (Sigma-Aldrich, USA)
was used as standard.
Cu/Zn-superoxide dismutase (Cu/Zn-SOD) and catalase
(CAT)
Superoxide dismutase (Cu/Zn SOD; EC 1.15.1.1) activity
was estimated in the lysate of EAC cells according to
Misra and Fridovich [37]. The rate of inhibition of auto
oxidation was monitored at 560 nm; the amount of
enzyme required to produce 50% inhibition is defined as
one unit of enzyme activity. SOD activity was expressed
as units/mL. Catalase (CAT; EC 1.11.1.6) activity was
determined using the method of Aebi [38]. Samples
were prepared in phosphate buffer (50 mM, pH 7) and
Triton-X 100 (1%, v/v) was added to increase the ob-
servable CAT activity by releasing the enzyme from
peroxisomes [39]. CAT was measured by monitoring
the decomposition of H2O2 at 240 nm. The enzyme
activity was calculated using a molar extinction coeffi-
cient of 43.6 mol.
Total antioxidant capacity (TAC)
The total antioxidant capacity in EAC cell lysates was
determined according to Koracevic et al. [40]. As in
our previous work [26], the ability of antioxidants
to inhibit the H2O2-induced oxidation of 2,2’-azinobis
(3-ethylbenzothiazoline-6-sulphonate; ABTS) was mea-
sured spectrophotometrically by the reduction in concen-
tration of the cation radical ABTS+, absorbing at 600 nm
and expressed as mmol/L.
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SPSSW statistical software (v. 17.01 SPSS Inc., USA)
was used in all data analyses [41]. Descriptive analyses
including mean and standard error were applied to all
biochemical measurements. Differences in the effects
of Conus venom between control and treated groups
were assessed using the Student's unpaired t-test [42].
One-way analysis of variance (ANOVA) followed by a
Dunnett post hoc test was performed to evaluate even-
tual significant differences in the biochemical measure-
ments between control and treated groups.
Results
In vitro cytotoxicity of Conus venom
The membrane integrity of EAC cells treated with C.
vexillum venom, obtained from either Hurgada or
Sharm El-Shaikh, was evaluated by measuring the levels
of LDH activity in cell culture supernatants. LDH levels
in cells incubated with Conus venom for one hour from
each location showed a significant (p < 0.05) dose-
dependent increase in comparison to the levels in
vehicle-treated cells (Table 1). At doses of 10, 20 and
30 μg/mL of Hurgada venom, release of LDH in-
creased to 48.9, 131.7 and 196.7% respectively, with re-
spect to the control. For Sharm El-Shaikh venom,
analogous values were 43.6, 107.5 and 171.9%, with re-
spect to the control. Over the course of the experi-
ment, Hurgada venom was more potent than Sharm
El-Shaikh venom in increasing LDH levels and was
statistically significant (p < 0.05) at ≥ 20 μg/mL venom.
In vivo cytotoxic effects of Conus venom on EAC cells
There are several assays available to measure oxidative
stress. One such indicator is the extent of lipid peroxida-
tion (LPx) as measured by thiobarbituric acid derivatives
of key metabolic markers such as malondialdehyde
(MDA). Protein carbonylation (PCC) is generally recog-
nized as a key step in the production of oxidized
proteins and the conversion of NO to nitrite and nitrate
is typical metabolic event in oxygenated solutions. The
results in Figure 1 illustrate the effects of injection of
C. vexillum venom (1.25 mg/kg) from each locationTable 1 Changes in LDH levels of EAC cells incubated with Co
El-Shaikh (Red Sea, Egypt)
Venom concentration
(μg/mL) Control
10 295.53 ± 8.1a
20
30
aValues are presented as mean ± SE (n = 5 per group). Values between brackets rep
group) and treated group using Student’s unpaired t-test (p < 0.05). #Represents a s
Student’s unpaired t-test (p < 0.05).into tumor-bearing mice, on the oxidative stress bio-
markers (LPx, PCC and NO) at different time intervals
(3, 6, 9 and 12 hours).
It was observed that LPx (as measured by MDA con-
centration) was significantly increased (p < 0.05) at all
time intervals in both Hurgada and Sharm El-Shaikh
venoms with respect to control groups (Figure 1 – A).
However, levels of MDA increased more rapidly after in-
jection of Hurgada venom (up to 235% increase over
control levels after three hours); injection of Sharm
El-Shaikh venom took twice as long to produce in-
creased levels of MDA (up to 164% after six hours)
which were considerably lower than that produced by
Hurgada venom. One-way ANOVA revealed that differ-
ences in the concentration of LPx products between
treated groups of Sharm El-Shaikh venoms was not as
great (F1,3 = 35.86, p < 0.001) as Hurgada venoms (F1,3 =
111.69, p < 0.001). Analysis of LPx products revealed
significant effects for venom (F2,72 =13.01, p < 0.05), time
(F3,72 = 71.80, p < 0.001) and the interaction of venom
and time (F6,72 = 24.16, p < 0.001) using two-way
ANOVA.
The PCCs of EAC cells from mice injected with both
venom groups were significantly increased (p < 0.05)
at all times intervals compared with control values
(Figure 1 – B). On average, Hurgada venom was
approximately 1.4 times as potent as Sharm El-Shaikh
venom in inducing protein oxidation. Using one-way
ANOVA, significant differences in PCCs were detected
between the treated groups of both Hurgada and
Sharm El-Shaikh (F1,3 = 470.04, p < 0.001 and F1,3 = 221.80,
p < 0.001, respectively). According to the post hoc
comparisons, six hours of Hurgada venom treatment
produced the maximum increase (+ 501%) in protein
oxidation relative to control. Using two-way ANOVA,
PCCs revealed significant effects for venom (F2,72 = 663.60,
p < 0.001), time (F3,72 = 214.33, p < 0.001) and the inter-
action of venom and time (F6,72 = 45.54, p < 0.001). Conus
venom enhanced production of NO in Hurgada venom-
injected animals (Figure 1 – C) and by six hours there was
a 61% increase in levels of NO with respect to controls
(p < 0.05). In comparison, injection of Sharm El-Shaikhnus vexillum venom collected from Hurgada and Sharm
LDH Activity (U/L)
Hurgada Sharm El-Shaikh
439.98 ± 10.6* (+48.9) 424.38 ± 9.0* (+43.6)
684.58 ± 8.3* (+131.7) 613.18 ± 8.7*,# (+107.5)
875.00 ± 12.1* (+196.7) 803.6 ± 11.5*,# (+171.9)
resent percent of change. *Significant difference between control (EAC control
ignificant difference between Hurgada and Sharm El-Shaikh groups using
Figure 1 Conus vexillum venom (1.25 mg/kg) collected from Hurgada and Sharm El-Shaikh induced intracellular oxidative stress in EAC cells
assessed by the level of (A) lipid peroxidation, (B) protein carbonyl content and (C) level of nitric oxide. *Significant difference between control
(EAC control group) and treated group using Student’s unpaired t-test (p< 0.05). #Represents a significant difference between Hurgada and Sharm El-Shaikh
groups using Student’s unpaired t-test (p< 0.05). £Significant difference between treated groups using one-way ANOVA (p< 0.05).
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Differences between Hurgada and Sharm El-Shaikh were
statistically significant (p < 0.05) up to six hours post in-
jection. Statistical analysis of NO levels revealed signifi-
cant effects for venom (F2,72 = 491.74, p < 0.001), time(F3,72 = 77.17, p < 0.001) and the interaction of venom
and time (F6,72 = 42.09, p < 0.001).
The in vivo effects of injecting Conus venom into
EAC-tumor-bearing mice, on the activities of representa-
tive oxidative defense enzymes (CAT and Cu/Zn-SOD)
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GSH (as a non-enzymatic antioxidant) and the total
antioxidant capacity (TAC). The level of cellular GSH
was significantly decreased (p < 0.05) at all time intervals
in mice injected with Hurgada venom, continuing to de-
cline to 46% of control levels at 12 hours (Figure 2 – A).
By comparison, in mice injected with Sharm El-Shaikh
venom, the levels of GSH declined at a slower rate and
began to recover after nine hours (Figure 2 – A). Using
bivariate analysis of covariance, cellular GSH brought
significant effects for venom (F2,72 = 81.80, p < 0.001),
time (F3,72 = 42.00, p < 0.001) and the interaction of
venom and time (F6,72 = 4.27, p < 0.05).
There was a significant decrease (p < 0.05) in the activ-
ities of both CAT and Cu/Zn-SOD in mice injected with
either Hurgada and Sharm El-Shaikh venoms at all time
intervals as compared with the control groups. The pat-
tern of CAT and SOD levels was the same in both
Hurgada and Sharm El-Shaikh venoms, declining to a
maximum of approx 56% and 47% respectively in the
two locations, at nine hours (Figure 2 – B and C). Inter-
estingly, GSH levels at the different time points mirrored
CAT and Cu/Zn SOD levels in the case of Sharm
El-Shaikh venom, with a partial recovery after nine
hours. Unpaired t-tests showed significant decreases in
the level of TAC in EAC cells from both venom groupsFigure 2 Changes in the antioxidant measurements GSH (panel A), CA
after administration of Conus vexillum venom (1.25 mg/kg) collectedat all time intervals as compared with the control group
(p < 0.05). In distinction to the other antioxidant
markers, there was a significant decrease in TAC levels
in mice injected with Hurgada venom, in the second
time period (47% decline from control levels at six
hours). In comparison, TAC levels in mice injected
with Sharm El-Shaikh venom declined more slowly,
although the eventual amount of decline was very simi-
lar (51% decline from control levels after nine hours)
(Figure 2 – D). Moreover, the activities of oxidative
defense enzymes (CAT and SOD) and TAC showed sig-
nificant effects for venom (F2,72 = 4.09, 0.34 and 2.61,
p < 0.05), time (F3,72 = 33.1, 42.5 and 30.1, p < 0.001)
and the interaction of venom and time (F6,72 = 1.69, 1.7
and 6.1, p < 0.05), respectively.
Discussion
Venoms from marine cone snails (Conus) have received
much attention over the last few decades due to their
extraordinary complexity and diversity [43]. Each Conus
species synthesizes its own characteristic repertoire
of ∼ 1100-1900 toxin peptides, and it has been estimated
that the toxin library of the entire cone snail genus com-
prises as many as 500,000 different bioactive compounds
[24,44]. The vast majority of these peptides have been
shown to target various types of ion channels, bothT (panel B), Cu/Zn SOD (panel C) and TAC (panel D) of EAC cells
from Hurgada and Sharm El-Shaikh.
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there are only a few reports describing the cytotoxic ac-
tions of Conus venoms on eukaryotic cells [26,46,47].
The first cytolytic peptide (conolysin-Mt) was iso-
lated from the vermivorous cone snail venom Conus
mustelinus [47]. The characterization of conolysin
expanded the known repertoire of conopeptide mecha-
nisms to include membrane perturbation. Cytolytic
peptides, defined by their ability to partially or com-
pletely destroy cell membranes, are among the largest
group of toxins produced by living organisms, which
include bacteria, viruses, insects, scorpions, spiders,
reptiles, and marine invertebrates [48]. By targeting
the lipid bilayer of the cell membrane, cytolytic pep-
tides can affect a wide range of biological processes. In
our study, an attempt has been made to elucidate the
cytotoxic potential of Conus venom (collected from
Hurgada and Sharm El-Shaikh) and its underlying
mechanism of action, using EAC cells.
The cytotoxic potential of Conus venom from these
two geographical sites has been evaluated in vitro against
EAC cells by measuring LDH activity. It is well docu-
mented that the in vitro release of LDH provides an
accurate measure of cell membrane integrity and cell
viability. This assay is based on the release of the cyto-
solic enzyme LDH from cells, which catalyses the
conversion of lactate to pyruvate and cannot be detected
extracellularly unless cell damage has occurred. The
LDH levels in EAC cells incubated with Conus venom
for one hour showed a significant (p < 0.01) dose-
dependent increase in comparison to the levels in
vehicle-treated cells. The release of LDH indicates a
loss of cell membrane integrity and is therefore an in-
direct method to assess the venom-induced cytotox-
icity [20,49]. Abdel-Rahman et al. [26] attributed the
direct cytotoxic effects of C. vexillum on mammalian
cells to the presence of proteolytic enzymes in the
crude venom. Proteolytic enzymes in Conus venom are
primarily responsible for venom-induced necrotic
activity and could be injected by cone snails to elicit
proteolytic degradation of the extracellular matrix in
the prey [46]. Indeed, Cathepsin D and kallikrein-like
proteins have recently been identified in the venom
glands of C. victoriae and C. novaehollandiae, respect-
ively [43]. Cathepsin D (aspartyl protease) and kallikrein
(trypsin and serine proteases) have also been found in
other animal venoms [50-52].
Interestingly, our toxicological data revealed significant
differences in the efficacy of C. vexillum venom collected
from the two Egyptian locations, Hurgada and Sharm
El-Shaikh. The data showed that the venom obtained
from Hurgada was more potent than that obtained from
Sharm El-Shaikh. We have attributed the difference in
venom potency to variation in the expression of peptidesfrom C. vexillum collected from these two locations
[26]. For example, the presence of the m/z peptide
2924.7 (calcium channel blocker) in the venom of Sharm
El-Shaikh may explain why venom-induced oxidative
stress was significantly higher in the case of Hurgada
venom. The presence of this calcium channel blocker in
Sharm El-Shaikh venom delays rises in intracellular
calcium concentrations in venom-treated cells and hence
slows the elevation of oxidative stress markers in
comparison with Hurgada venom [26].
It is well documented that oxidative stress is extremely
deleterious to cells and reactive oxygen species (ROS)
are engaged in the etiology and progression of several
diseases including cancer. Several environmental oxi-
dants such as heat shock, UV irradiation, infections, and
toxins [26,53,54] can induce oxidative stress that shifting
the cellular redox status to a more oxidized state. In nor-
mal conditions, enzymatic and non-enzymatic antioxi-
dants are capable of neutralizing harmful effects of ROS
and protect cellular components from damage. However,
under conditions of excessive oxidative stress, ROS can
damage cellular components and interfere with critical
cellular activities [55]. Numerous studies have provided
evidence that ROS are directly involved in oxidative
damage with cellular macromolecules such as lipids,
proteins and nucleic acids, leading to cell death [56].
Cancer cells have active protective mechanisms to pre-
vent lipid peroxidation. It has been demonstrated that
the presence of relatively low levels of the NADPH-
cytochrome-P450 electron transport chain may explain
the remarkable decrease of lipid peroxidation in cancer
cells when compared to normal cells [57].
In order to examine Conus venom induced oxida-
tive stress, the changes of intracellular ROS of EAC
cells were measured. Conus venom administration
(1.25 mg/kg) to tumor-bearing albino mice induced
significant increases in the oxidative stress biomarkers
(MDA, PCC) of the propagated EAC cells. We have
recently suggested possible mechanisms by which the
venom of C. vexillum induces cellular oxidative dam-
age in murine cells [26]. Damage could be attributed
to phospholipase A2 activity – for example an enzyme
analogous to conodipine-M – on cell membranes, causing
the release of arachidonic acid [58]. Arachidonic acid can
potentiate cell damage by converting apoptosis to necrosis
through lipid peroxidation and the promotion of DNA
fragmentation [59].
NO may also play a prominent role in cytotoxicity in-
duced by Conus venom. Our results showed that Conus
venom significantly increased the production of NO in
the ascites fluid of treated animals, especially in Hurgada
venom. The elevation of NO levels may be due to the
activation of macrophages present in the ascites fluid. It
has been found that macrophages play an important role
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initiate cell death programs through the release of
soluble immune mediators [61]. One mechanism that
macrophages use to exert their cytolytic effects on target
tumors is by the release of NO through activation of
NADPH-dependent NO synthase [62,63]. NO can cause
growth arrest and apoptosis because of its high reactivity
with iron-and thiol-containing macromolecules, thereby
inhibiting enzymes of the TCA cycle and those involved
in mitochondrial respiration, as well as DNA synthesis
and repair [64,65]. It can be noted that our data revealed
that increases in NO levels paralleled a significant
increase in the level of PCC, which is an indication of
protein damage of EAC cells.
Several previous studies have clarified the influence
of ROS overproduction on intracellular Ca2+ levels.
Chandra et al. [66] found that increases in the concen-
trations of intracellular ROS were a sign of the onset of
apoptotic processes; they cited ROS production as a
critical determinant of the toxicity associated with
exposure to chemotherapeutic drugs. It has been
shown that oxidative stress increases intracellular Ca2+
concentrations, leading to activation of endonucleases
which degrade DNA and, ultimately, contribute to cell
damage [67]. Orrenius et al. [68] found that free rad-
ical overproduction may inhibit Ca2+ ATPases and this
leads to altered regulation of Ca2+ levels and cell death.
Ermak et al. [53] clearly demonstrated the influence of
rising intracellular Ca2+ concentration induced by oxi-
dative stress. They found that oxidative stress increases
the process of Ca2+ diffusion from both the endoplas-
mic reticulum and extracellular environment into the
cytoplasm. Consequently, the elevation of cytoplasmic
Ca2+ concentrations causes Ca2+ influx into both mito-
chondria and nuclei. High concentration of Ca2+ in
mitochondria leads to cell damage through disruption
normal cellular metabolism. In nuclei, high Ca2+ levels
modulate transcription factors and nucleases that
regulate cell apoptosis. Moreover, the enzymes (e.g.
nitric oxide synthase) that produce free radicals can be
activated by the elevation of Ca2+ level [69]. Therefore,
by increasing cytoplasmic Ca2+ concentrations, oxidants
can also indirectly cause more oxidant production and
further raise Ca2+ levels.
In the present work, increased levels of cellular oxi-
dative stress in EAC cells treated with Conus venom
were also accompanied by a remarkable decrease in
the levels of antioxidants in treated cells. The results
clearly demonstrated that Conus venom significantly
reduced the content of GSH of tumor cells. Modifica-
tions of GSH metabolism have been postulated as be-
ing useful in cancer therapy [70]. Indeed, the
elevation of intracellular GSH content has been asso-
ciated with mitogenic stimulation [71,72]. GSH hasbeen suggested as a potential regulator of protein syn-
thesis, DNA synthesis and cell proliferation [72,73].
Several previous in vivo and in vitro studies have re-
vealed that the amino acid precursors (glutamine and
methionine) for GSH synthesis play a crucial role in
cancer metabolism. Tumour cells use the amino acid
glutamine as a main respiratory fuel [74] and methio-
nine in cell growth [75]. Moreover, our data showed
that the depletion of GSH content was concomitant
with a reduction in the activity of enzymatic antioxi-
dants (CAT and SOD) as well as a reduction in the
level of TAC. The observed reduction in the level of
antioxidants of tumor cells from venom-treated ani-
mals may explain the role of oxidative stress in cell
damage. It is well established that antioxidant defense
enzymes such as SOD and CAT play a crucial role in
maintaining cellular homeostasis by detoxifying the
generated ROS such as superoxide radicals and H2O2
[76]. Our findings are corroborate those of Sun et al.
[77], who reported that the inhibition of cell growth
and apoptotic activity of the snake venom fraction
OHAP-1 (Okinawa Habu apoxin protein-1) was re-
versed by the addition of GSH and catalase to rat and
human malignant glioma cell lines.Conclusions
Conus venoms have provided extensive libraries of toxins
active against a diverse range of ion channel proteins,
belonging to both voltage-gated and neurotransmitter-
activated gene families. The recognition that cone snails
also have cytolytic peptides in their venom arsenals
should not be surprising, given that similarly acting
peptides in snake venom have been known for thirty
years but it was only a few years ago that the first
Conus venom cytolytic peptide, conolysin MT was
discovered [47]. Our present study aims at contribut-
ing to the study of the mechanism of action of these
cytolytic toxins from Cone snails that interact with
and disrupt cell membranes. Our data indicate that C.
vexillum venom contains components which induce
oxidative stress mechanisms in Erhlich’s ascites
carcninoma cells and suggest that the venom contains
novel molecules with potential anticancer activity.Ethics committee approval
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